ProMed Pharma LLC, a leading provider of polymer-based drug delivery solutions, announces the acquisition of a 28,000 square foot, state-of-the-art pharmaceutical manufacturing facility located at 2200 N Niagara Lane, Plymouth, Minnesota. The facility was previously owned and operated by Bora Pharmaceuticals, a global contract development and manufacturing organization. This strategic acquisition expands ProMed Pharma’s footprint and enhances its commercial manufacturing capabilities in complex drug delivery systems, enabling the company to better serve its growing base of pharmaceutical and biotech partners.
Read the full article: ProMed Pharma Announces Acquisition of Manufacturing Facility from Bora Pharmaceuticals //
Source: https://www.einpresswire.com/article/840961031/promed-pharma-announces-acquisition-of-manufacturing-facility-from-bora-pharmaceuticals